Search Results for "drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for drug. Results 1701 to 1710 of 2605 total matches.
Belimumab (Benlysta) for Lupus Nephritis (online only)
The Medical Letter on Drugs and Therapeutics • Sep 23, 2021 (Issue 1634)
therapy for treatment of active lupus nephritis in
adults.1 Belimumab is the first drug to be approved ...
The B-lymphocyte stimulator (BLyS)-specific inhibitor
belimumab (Benlysta – GSK), which was approved
earlier for treatment of active, autoantibody-positive,
nonrenal, systemic lupus erythematosus (SLE), has
now been approved for use in addition to standard
therapy for treatment of active lupus nephritis in
adults. Belimumab is the first drug to be approved in
the US for treatment of both SLE and lupus nephritis.
Rivaroxaban (Xarelto) - A New Peripheral Artery Disease Indication
The Medical Letter on Drugs and Therapeutics • Nov 01, 2021 (Issue 1636)
(Farxiga) – a new indication for heart failure.
Med Lett Drugs Ther 2020; 62:102.
2. Drugs for type 2 ...
The FDA has approved an expansion of the
peripheral artery disease (PAD) indication for the
oral direct factor Xa inhibitor rivaroxaban (Xarelto – Janssen) to include patients who have recently
undergone a lower extremity revascularization
procedure for symptomatic PAD (see Table 1).
Rivaroxaban is the first direct oral anticoagulant
(DOAC) to be approved for use in patients with PAD.
Delandistrogene Moxeparvovec (Elevidys) for Duchenne Muscular Dystrophy
The Medical Letter on Drugs and Therapeutics • Oct 02, 2023 (Issue 1686)
Clin Med 2021; 10:820.
2. Deflazacort (Emflaza) for Duchenne muscular dystrophy. Med
Lett Drugs Ther ...
Delandistrogene moxeparvovec-rokl (Elevidys –
Sarepta), an adeno-associated virus (AAV) vector-based
gene therapy, has received accelerated
approval from the FDA for treatment of ambulatory
children 4-5 years old with Duchenne muscular
dystrophy (DMD) who have a confirmed mutation in
the dystrophin gene. It is the first gene therapy to be
approved in the US for treatment of DMD. Accelerated
approval was based on expression of microdystrophin
in skeletal muscle, a surrogate endpoint.
Med Lett Drugs Ther. 2023 Oct 2;65(1686):159-60 doi:10.58347/tml.2023.1686d | Show Introduction Hide Introduction
Datopotamab Deruxtecan (Datroway) for Advanced Breast Cancer (online only)
The Medical Letter on Drugs and Therapeutics • Mar 03, 2025 (Issue 1723)
, and ocular adverse effects.
▶ Drug Interactions: No clinically significant drug interactions.
▶ Dosage: 6 ...
The FDA has approved datopotamab deruxtecan
(Datroway – Daiichi Sankyo/AstraZeneca), a trophoblast
cell-surface antigen-2 (Trop-2)-directed antibody
and topoisomerase inhibitor conjugate, for treatment
of adults with unresectable or metastatic hormone
receptor (HR)-positive, human epidermal growth factor
receptor 2 (HER2)-negative breast cancer who received
prior endocrine-based therapy and chemotherapy for
unresectable or metastatic disease.
Med Lett Drugs Ther. 2025 Mar 3;67(1723):e41-2 doi:10.58347/tml.2025.1723e | Show Introduction Hide Introduction
Tiopronin for Cystinuria
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989 (Issue 784)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Tiopronin (Thiola - Mission), a thiol compound (mercaptopropionyl glycine) that solubilizes cystine by reacting with it to form a mixed disulfide, is now available in the USA for treatment of refractory cystinuria.
Eribulin Mesylate (Halaven) for Breast Cancer
The Medical Letter on Drugs and Therapeutics • Apr 18, 2011 (Issue 1362)
The Medical Letter®
On Drugs and Therapeutics
Volume 53 (Issue 1362)
April 18, 2011 ...
Eribulin mesylate (Halaven – Eisai) has been
approved by the FDA for treatment of patients with
metastatic breast cancer who have previously
received at least 2 chemotherapy regimens for
metastatic cancer. Prior therapy should have
included an anthracycline and a taxane in either an
adjuvant or metastatic setting. Other drugs used to
treat anthracycline- and taxane-refractory metastatic
breast cancer include capecitabine (Xeloda),
gemcitabine (Gemzar, and others) and vinorelbine
(Navelbine, and others).
Off-Label Use of Ketorolac for Athletic Injuries
The Medical Letter on Drugs and Therapeutics • May 14, 2012 (Issue 1390)
The Medical Letter®
On Drugs and Therapeutics
Volume 54 (Issue 1390)
May 14, 2012 ...
Recent reports indicate that intramuscular (IM) injection
of the nonsteroidal anti-inflammatory drug
(NSAID) ketorolac (Toradol, and others), sometimes
directly into injured muscles, has become a common
practice in US locker rooms.
Rethinking Warfarin for Atrial Fibrillation
The Medical Letter on Drugs and Therapeutics • Sep 30, 2013 (Issue 1426)
The Medical Letter®
On Drugs and Therapeutics
Volume 55 (Issue 1426)
September 30, 2013 ...
Full-page newspaper advertisements and a series of television
commercials have urged patients with atrial fibrillation
to "rethink warfarin" in favor of Eliquis (apixaban –
Bristol-Myers Squibb). Apixaban is the latest of 3 new oral
anticoagulants now competing with warfarin (Coumadin,
and others) for the oral anticoagulant market.
In Brief: Low-Dose Chlorthalidone (HemiClor) for Hypertension
The Medical Letter on Drugs and Therapeutics • Jul 21, 2025 (Issue 1733)
for hypertension.
Med Lett Drugs Ther 2012; 54:17.
2. Drugs for hypertension. Med Lett Drugs Ther 2024; 66:81.
3 ...
The FDA has approved a 12.5-mg tablet formulation
of the thiazide-like diuretic chlorthalidone (HemiClor –
Ingenus) for treatment of hypertension. Chlorthalidone
has been available for years in 15-, 25-, and 50-mg
tablets (Thalitone, and generics) and in fixed-dose
combinations with azilsartan medoxomil (Edarbyclor)
and atenolol (Tenoretic, and generics).
Med Lett Drugs Ther. 2025 Jul 21;67(1733):118 doi:10.58347/tml.2025.1733e | Show Introduction Hide Introduction
Bivalirudin (Angiomax) For Angioplasty
The Medical Letter on Drugs and Therapeutics • Apr 30, 2001 (Issue 1103)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Bivalirudin is being promoted as an intravenous (IV) anticoagulant that can be used instead of heparin in patients with unstable angina undergoing coronary angioplasty.